EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS086-04214 
Organism
Homo sapiens 
Tissue/cell
HEK293 
Coordinate
chr16:2136380-2136730 
Target genes
Number: 47             
NameEnsembl ID
TELO2ENSG00000100726
IFT140ENSG00000187535
CRAMP1LENSG00000007545
LA16cENSG00000261207
NME3ENSG00000103024
XXENSG00000259947
HS3ST6ENSG00000162040
MSRB1ENSG00000198736
RPL3LENSG00000140986
NDUFB10ENSG00000140990
SNORA10ENSG00000206811
SNORA64ENSG00000207405
AC005363.9ENSG00000255513
RPS2ENSG00000140988
SNHG9ENSG00000255198
SNORA78ENSG00000238671
RNF151ENSG00000179580
TBL3ENSG00000183751
GFERENSG00000127554
AC005606.15ENSG00000260107
ZNF598ENSG00000167962
SLC9A3R2ENSG00000065054
TSC2ENSG00000103197
NTHL1ENSG00000065057
RP11ENSG00000259933
PKD1ENSG00000008710
RAB26ENSG00000167964
TRAF7ENSG00000131653
CASKIN1ENSG00000167971
MLST8ENSG00000167965
C16orf79ENSG00000182685
PGPENSG00000184207
E4F1ENSG00000167967
DNASE1L2ENSG00000167968
ECI1ENSG00000167969
AC009065.1ENSG00000167970
RNPS1ENSG00000205937
ABCA17PENSG00000238098
ABCA3ENSG00000167972
CCNFENSG00000162063
C16orf59ENSG00000162062
NTN3ENSG00000162068
TBC1D24ENSG00000162065
ATP6V0CENSG00000185883
AMDHD2ENSG00000162066
PDPK1ENSG00000140992
KCTD5ENSG00000167977
Number of super-enhancer constituents: 2             
IDCoordinateTissue/cell
SE_24871chr16:2135358-2144629Colon_Crypt_3
SE_42044chr16:2134666-2137448LNCaP
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr1621365902136640
Number: 1             
IDChromosomeStartEnd
GH16I002086chr1621367292144555
Enhancer Sequence
GTACGGCCTG GCGCCTACCC GCTCCTGCTG CCCCAGGCCT CAGGGCACGG CTCCCATCCA 60
GTCCTGCTAC CCCACGCCCT GGGGCATGGC CCTGGCACCC CCACCTGCTC CAGCTCCCCA 120
CGCCTCAGGT TCCGAGCCTA ACAGCGTGGG CATGGAGGCA GTGATGGGGC TGGTGGCTTT 180
GCGTCCCAAA GCCCTGCCCC TGGGGAGAGC CGAGGACCAC TGGCCAGGCA CCAGAGGACG 240
TGGTCCCCGC AGGCCCCCAG AGCCCCTGGA GTAATCAGGA GGTGCCCCAG TGCAAGGCAC 300
AGAGGGCCTC AGCACTGGCC CCACAAACCC ATCCGGCCCT GCTCACCCTC 350